# A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

> **NCT06398730** · PHASE1 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** GEH200520 Injection and GEH200521 (18F) Injection
- **DIAGNOSTIC_TEST:** Static - PET/CT scan

## Key facts

- **NCT ID:** NCT06398730
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-02
- **Primary completion:** 2026-02-19
- **Final completion:** 2026-02-23
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06398730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06398730, "A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06398730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*